Reset all filters
01 2AMISULPRIDE
02 2BENDAMUSTINE HYDROCHLORIDE
03 1DANTROLENE SODIUM
04 1PEMETREXED
05 1REMIMAZOLAM BESYLATE
06 1VASOPRESSIN
Reset all filters
01 1FOR SUSPENSION;INTRAVENOUS
02 1POWDER;INTRAVENOUS
03 6SOLUTION;INTRAVENOUS
Reset all filters
01 2100MG/4ML (25MG/ML)
02 110MG/4ML (2.5MG/ML)
03 120UNITS/ML (20UNITS/ML)
04 1250MG/VIAL
05 1500MG/20ML (25MG/ML)
06 15MG/2ML (2.5MG/ML)
07 1EQ 20MG BASE/VIAL
Reset all filters
01 8RX
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : BARHEMSYS
Dosage Strength : 5MG/2ML (2.5MG/ML)
Approval Date : 2020-02-26
Application Number : 209510
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : BARHEMSYS
Dosage Strength : 10MG/4ML (2.5MG/ML)
Approval Date : 2020-09-01
Application Number : 209510
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AP
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : BELRAPZO
Dosage Strength : 100MG/4ML (25MG/ML)
Approval Date : 2018-05-15
Application Number : 205580
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : BENDEKA
Dosage Strength : 100MG/4ML (25MG/ML)
Approval Date : 2015-12-07
Application Number : 208194
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : FOR SUSPENSION; INTRAVENOUS
Proprietary Name : RYANODEX
Dosage Strength : 250MG/VIAL
Approval Date : 2014-07-22
Application Number : 205579
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : PEMFEXY
Dosage Strength : 500MG/20ML (25MG/ML)
Approval Date : 2020-02-08
Application Number : 209472
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : POWDER; INTRAVENOUS
Proprietary Name : BYFAVO
Dosage Strength : EQ 20MG BASE/VIAL
Approval Date : 2020-10-06
Application Number : 212295
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : VASOPRESSIN
Dosage Strength : 20UNITS/ML (20UNITS/ML)
Approval Date : 2021-12-15
Application Number : 211538
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
